New Therapies for Effectively Treating Psoriatic Arthritis

In this video, Douglas Lienesch, MD, assistant professor in the division of rheumatology and clinical immunology at the University of Pittsburgh Medical Center, offers an overview of available medications for the treatment of psoriatic arthritis.

In this video, Douglas Lienesch, MD, assistant professor in the division of rheumatology and clinical immunology at the University of Pittsburgh Medical Center, offers an overview of available medications for the treatment of psoriatic arthritis.

Related Videos
Public Health Matters podcast logo
Smiling Asian female pharmacist working in chemist shop or pharmacy | Image Credit: Atstock Productions - stock.adobe.com
sofiko14 / stock.adobe.com
Mammogram scans | Image credit: okrasiuk - stock.adobe.com
WP_7824 / stock.adobe.com
tilialucida / stock.adobe.com
vectorfusionart / stock.adobe.com
Related Content

FDA Approves Adalimumab-adaz High-Concentration Formulation Biosimilar

March 21st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023

FDA Approves Adalimumab-adaz High-Concentration Formulation Biosimilar

March 21st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023

FDA Approves Adalimumab-adaz High-Concentration Formulation Biosimilar

March 21st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023
© 2023 MJH Life Sciences

All rights reserved.